Hi all,
Now reseachers report that they have developed a preclinical drug test platform that would enable them to analyse tumour tissue for individual patient drug responses on the molecular level.
So far they only study solid tumors but the method could probably soner or later be used for hematological cancers too.
http://www.sciencedaily.com/releases...0923102329.htm
Kind regards
Birgitta-A